Oruka Therapeutics, Inc.
ORKA
$29.91
$2.087.47%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -15.02% | 2,071.85% | 1,158.31% | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 189.68% | 153.05% | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | -13.99% | 1,873.79% | 1,169.09% | ||
|
|
|||||
| Total Current Assets | -13.99% | 1,873.79% | 1,169.09% | ||
| Net Property, Plant & Equipment | 102.37% | 125.23% | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 139.53% | -95.63% | -78.89% | ||
| Total Assets | 22.98% | 1,671.33% | 1,235.81% | ||
|
|
|||||
| Total Accounts Payable | 2.94% | 80.85% | 88,525.00% | ||
| Total Accrued Expenses | 7.30% | -77.31% | -7.92% | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 186.99% | 981.97% | -- | ||
| Total Finance Division Other Current Liabilities | 26.08% | 618.37% | 1,041.13% | ||
| Total Other Current Liabilities | 26.08% | 618.37% | 1,041.13% | ||
| Total Current Liabilities | 16.23% | -37.45% | 63.61% | ||
|
|
|||||
| Total Current Liabilities | 16.23% | -37.45% | 63.61% | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 77.32% | 80.11% | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | 18.96% | -70.20% | -61.72% | ||
|
|
|||||
| Common Stock & APIC | 61.87% | 138,553.39% | 2,591,694.44% | ||
| Retained Earnings | -175.40% | -340.99% | -1,379.77% | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | 42.55% | 1,275.64% | 5,225.29% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -94.74% | 0.00% | 0.00% | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -94.74% | 0.00% | 0.00% | ||
|
|
|||||
| Total Common Equity | 42.55% | 1,275.64% | 5,225.29% | ||
| Total Preferred Equity | -94.74% | 0.00% | 0.00% | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 23.17% | 1,419.16% | 8,935.39% | ||
|
|
|||||